ENTITY
Rendu Bio
Rendu Bio
PulseAugur coverage of Rendu Bio — every cluster mentioning Rendu Bio across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TIMELINE
- 2026-05-14 funding RenDu Bio's controlling shareholder is changing to Nanjing Haijing Pharmaceutical through a share transfer agreement. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
RenDu Bio's controlling shareholder to change to Haijing Pharmaceutical
RenDu Bio announced that its controlling shareholder, Jinliang Ju, and others will transfer approximately 8.52 million shares to Nanjing Haijing Pharmaceutical for about 516 million yuan. Following this transaction, Hai…
-
Yi Ming Pharma shareholder plans to reduce stake by 1%
Yi Ming Pharmaceutical announced that shareholder Zhou Zhan plans to reduce his stake by no more than 1% of the company's total shares. Separately, Rendu Bio announced that its controlling shareholder and actual control…